Qingrui Meng
Overview
Explore the profile of Qingrui Meng including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
83
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Holmqvist A, Meng Q, Landier W, Hageman L, Francisco L, Ross E, et al.
J Natl Cancer Inst
. 2025 Jan;
PMID: 39886926
Background: Human papillomavirus (HPV) is associated with an increased risk for a variety of squamous cell carcinomas (SCCs) in the general population. The risk for subsequent SCCs in BMT survivors...
2.
Broman K, Meng Q, Holmqvist A, Balas N, Richman J, Landier W, et al.
JAMA Dermatol
. 2024 Dec;
PMID: 39693095
Importance: Cutaneous malignant neoplasms are the most common subsequent neoplasm after blood or marrow transplant (BMT), but a full assessment among survivors is lacking. Objective: To identify risk factors for...
3.
Sun C, Lin Y, Meng Q, Li L
ISA Trans
. 2024 Nov;
156():457-467.
PMID: 39616041
This paper investigates an output feedback adaptive fault-tolerant tracking control for a class of nonlinear systems with system nonlinearities, sensor failures and external disturbances, in which sensor redundancy is employed...
4.
Balas N, Richman J, Landier W, Shrestha S, Bruxvoort K, Hageman L, et al.
Cancer
. 2024 Oct;
131(1):e35598.
PMID: 39380251
Background: The prevalence of suboptimal self-rated health (SRH) and its association with subsequent all-cause and cause-specific mortality after blood or marrow transplantation (BMT) were examined. Methods: Study participants were drawn...
5.
Xu Y, Liu C, Meng Q
Mol Biotechnol
. 2024 Oct;
PMID: 39354204
The incidence of thyroid cancer (THCA) has increased worldwide during the past 40 years. However, an understanding of the mechanisms and major transcription factors involved in THCA is insufficient to...
6.
Bostany G, Chen Y, Francisco L, Dai C, Meng Q, Sparks J, et al.
J Clin Oncol
. 2024 Jun;
43(1):32-45.
PMID: 38833638
Purpose: Cardiac dysfunction is the leading cause of mortality among 10-year breast cancer survivors. Limited information regarding long-term risks of cardiac dysfunction after cardiotoxic therapy (anthracyclines, trastuzumab/pertuzumab, radiation) has precluded...
7.
Balas N, Richman J, Landier W, Shrestha S, Bruxvoort K, Hageman L, et al.
Leukemia
. 2024 Apr;
38(7):1592-1599.
PMID: 38580835
We examined the prevalence, risk factors, and association between pre-frailty and subsequent mortality after blood or marrow transplantation (BMT). Study participants were drawn from the BMT Survivor Study (BMTSS) and...
8.
Holmqvist A, Meng Q, Dai C, Hageman L, Landier W, Wu J, et al.
Leukemia
. 2024 Feb;
38(3):601-609.
PMID: 38374408
We determined the risk of late morbidity and mortality after autologous blood or marrow transplantation (BMT) for lymphoma performed before age 40. The cohort included autologous BMT recipients who had...
9.
Oliver M, Meng Q, Hageman L, Landier W, Balas N, Ross E, et al.
Cancer
. 2023 Oct;
130(5):803-815.
PMID: 37880912
Background: Blood or marrow transplantation (BMT) survivors carry a high burden of morbidity, yet health care utilization by this vulnerable population remains understudied. Patterns and predictors of various domains of...
10.
Balas N, Richman J, Landier W, Shrestha S, Bruxvoort K, Hageman L, et al.
Blood Adv
. 2023 Sep;
7(22):7028-7044.
PMID: 37682779
We examined the association between risky health behaviors (smoking, heavy alcohol consumption, and lack of vigorous physical activity) and all-cause and cause-specific late mortality after blood or marrow transplantation (BMT)...